11:26 AM EDT, 08/28/2024 (MT Newswires) -- Catriona Yale, Chief Development Officer, on August 23, 2024, sold 14,051 shares in Akero Therapeutics ( AKRO ) for $386,714. Following the Form 4 filing with the SEC, Yale has control over a total of 75,931 shares of the company, with 75,931 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017024101257/xslF345X05/ownership.xml

Price: 26.21, Change: -0.11, Percent Change: -0.42